Delivery Order SPE2DB20D2002-SPE2DB26FK97U
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,336.38 on September 18, 2025, for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5mL syringes. The contract carries a firm fixed price and is scheduled for completion by October 9, 2025. This non-set-aside award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes, valued at $7,227.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 20, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.30 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringe format. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine vaccine procurement supporting the federal government's immunization...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ml syringes, with a ceiling value of $5,887.40. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,613.65 to supply Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, with an ultimate completion date of October 20, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The point of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $7,227.30 to supply Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. As a child contract, this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB26FK97UDelivery Order
The Defense Logistics Agency awarded a $1,445.44 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and related medical commodities—to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent competitively awarded recognition and the capability to meet complex medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/20/25 |